NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-311-2006-1-NL-13 Compositions And Methods For Chitosan Enhanced Immune Response NL EP 07838692.7 Abandoned
NCI E-311-2006-1-DK-08 Compositions And Methods For Chitosan Enhanced Immune Response DK EP 07838692.7 Abandoned
NCI E-311-2006-1-FR-10 Compositions And Methods For Chitosan Enhanced Immune Response FR EP 07838692.7 Abandoned
NCI E-311-2006-1-DE-07 Compositions And Methods For Chitosan Enhanced Immune Response DE EP 07838692.7 Abandoned
NCI E-311-2006-1-GB-11 Compositions And Methods For Chitosan Enhanced Immune Response GB EP 07838692.7 Abandoned
NCI E-311-2006-1-CH-06 Compositions And Methods For Chitosan Enhanced Immune Response CH EP 07838692.7 Abandoned
NCI E-311-2006-1-BE-05 Compositions And Methods For Chitosan Enhanced Immune Response BE EP 07838692.7 Abandoned
NCI E-311-2006-1-AT-04 Compositions And Methods For Chitosan Enhanced Immune Response AT EP 07838692.7 Abandoned
NCI E-311-2006-1-SE-14 Compositions And Methods For Chitosan Enhanced Immune Response SE EP 07838692.7 Abandoned
NCI E-311-2006-1-ES-09 Compositions And Methods For Chitosan Enhanced Immune Response ES EP 07838692.7 Abandoned
NIDCR E-018-2009-0-US-01 Differentially Expressed MicroRNAs as Biomarkers for the Diagnosis and Treatment of Sjogren's US 61/165,142 Abandoned
NCI E-332-2007-0-CA-05 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling CA National Stage 2720350 Abandoned
NIAID E-329-2000-0-US-07 ACYTHIOLS AND COMPONENT THIOL COMPOSITIONS AS ANTI-HIV AND ANTI-RETROVIRAL AGENTS US CON 12/414,321 8076372 Expired PDF
NIA E-241-2008-0-US-01 Posiphen And Analogues Suppress Production Of Alpha-synculein Protein US 61/164,729 Abandoned
NCI E-227-2006-5-GB-16 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS GB EP 07868382.8 Issued
NCI E-227-2006-5-DE-14 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS DE EP 07868382.8 Issued
NCI E-227-2006-5-FR-15 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS FR EP 07868382.8 Issued
NCI E-129-2008-0-PCT-02 Synthetic Analogs Of Juxtamembrane Domain Of IGF-1 Receptor As Anti-cancer Agents PCT PCT PCT/US09/38620 Expired
NICHD E-124-2008-0-PCT-02 Compounds and Methods for the Treatment of Viral Infection PCT PCT PCT/US2009/038644 Expired
NICHD E-124-2008-0-EP-03 Compounds and Methods for the Treatment of Viral Infection EP National Stage 09751057.2 Abandoned
NCI E-286-2006-2-US-02 SCGB3A2 As A Growth Factor and Anti-Apoptotic Agent US National Stage 12/442,927 8133859 Issued PDF
NIAID E-146-2008-2-PCT-01 Induction Of Profliferation, Molecule Expression And Cytolytic Capacity Of HIV -Specific CD8 + T Cells PCT PCT COMB PCT/US2009/001859 Expired
NCI E-079-2008-0-PCT-02 Human Anti-Mesothelin Monoclonal Antibodies PCT PCT PCT/US2009/038228 Expired
NIAID E-146-2008-2-EP-02 Induction Of Profliferation, Effector Molecule Expression And Cytolytic Capacity Of HIV -Specific CDS+ T Cells EP National Stage 09762793.9 Abandoned
NCI E-079-2008-0-EP-05 Human Anti-Mesothelin Monoclonal Antibodies EP National Stage 09726082.2 Abandoned
NCI E-079-2008-0-AU-03 Human Anti-Mesothelin Monoclonal Antibodies AU National Stage 2009228361 Abandoned
NCI E-079-2008-0-CA-04 Human Anti-Mesothelin Monoclonal Antibodies CA National Stage 2718321 Abandoned
NIDDK E-140-2008-0-CA-04 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists CA National Stage 2720037 Issued
NIDDK E-140-2008-0-ES-08 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists ES EP 09728154.7 Issued
NIDDK E-140-2008-0-DE-07 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists DE EP 09728154.7 Issued
NIDDK E-140-2008-0-FR-09 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists FR EP 09728154.7 Issued
NIDDK E-140-2008-0-IT-11 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists IT EP 09728154.7 Issued
NIDDK E-140-2008-0-GB-10 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists GB EP 09728154.7 Issued
NIDDK E-140-2008-0-EP-05 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists EP National Stage 09728154.7 Issued
NIDDK E-140-2008-0-AU-03 Purine Derivatives As A3 Adenosine Receptor-Selective Agonists AU National Stage 2009231978 Issued
NIDDK E-140-2008-0-PCT-02 Design Of (N)-Methanocarba Adenosine 5'Uronamides As Species-Independent A3 Receptor-Selective Agonists PCT PCT PCT/US2009/038026 Expired
NCI E-091-2009-0-US-01 Human Monoclonal Antibody Variable Fragments (Fvs) To Mesothelin US 61/162,778 Abandoned
NIDDK E-308-2006-3-US-01 Cross-Coupled Peptide Nucleic Acids For Detection Of Nucleic Acids Of Pathogens US CIP 12/409,159 Abandoned
NCI E-311-2006-1-US-03 Compositions And Methods For Chitosan Enhanced Immune Response US National Stage 12/442,483 Abandoned
NIAID E-150-2009-0-US-01 Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis US 61/162,588 Abandoned
NCI E-317-2008-0-PCT-01 Renal Cell Carcinoma Biomarkers PCT PCT PCT/US2009/037855 Expired
NIAID E-053-2008-1-PCT-01 Aerosolized Vaccines PCT PCT COMB PCT/US2009/001754 Expired
NIDDK E-151-2009-0-US-01 Nucleic Acids For The Detection Of Pathogens US 61/162,175 Abandoned
NIDDK E-109-2009-0-US-01 Inhibitors of Viral Integrase and Methods of Use Thereof US 61/161,469 Abandoned
NICHD E-146-2009-0-US-01 Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas US 61/161,568 Abandoned
NCI E-287-2009-2-US-01 Antiproliferative Factors And Methods Of Use US 61/161,349 Abandoned
NIAID E-148-2009-0-US-01 Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer US 61/161,223 Abandoned
NCI E-167-1997-0-JP-25 The Use of Nitroxide or a Prodrug Thereof In The Prophylactic And Therapeutic Treatment of Cancer JP DIV 2062-06-22 Abandoned
NCI E-191-2002-0-US-08 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US DIV 12/402,560 Abandoned
NCI E-158-2005-0-US-03 Peptide Epitopes Of Vegfr-2/Kdr that Inhibit Angiogenesis US CON 12/402,401 8378071 Abandoned PDF